Epiran 75 Tablets


Each tablet contains: Ranitidine HCl 75 mg.


  • Ranitidine HCl inhibits gastrin acid secretion elicited by histamine & other H2 agonists.
  • It also inhibits acid secretion elicited by gastrin and to a lesser extent by muscarinic agonists.
  •  It reduces both the volume of gastric juice secreted and the concentration of H+.


Dyspepsia, heartburn and as a maintenance therapy in peptic ulcer and reflux œsophagitis.

Dosage & Administration

Orally, One tablet three times daily and at bedtime when needed.


  • It is contraindicated for hypersensitive patients to Ranitidine HCl.
  • Caution should be considered in patients with renal & hepatic dysfunction.
  • Use during pregnancy under strict medical supervision.

Side Effects

Rarely, dizziness, insomnia, malaise & vertigo.


Box containing 2 strips of 10 tablets.

Epiran 75 Tablets is a product of Adwia Pharmaceuticals , Egypt – ATC Code: A02BA02